Group One Trading’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,315
Closed -$11.5K 8388
2022
Q4
$6.44K Buy
29,315
+7,628
+35% +$2.28K ﹤0.01% 6228
2022
Q3
$8K Buy
21,687
+2,594
+14% +$1.77K ﹤0.01% 6678
2022
Q2
$12K Sell
19,093
-2,824
-13% -$1.88K ﹤0.01% 6686
2022
Q1
$18K Buy
21,917
+100
+0.5% +$93 ﹤0.01% 6847
2021
Q4
$25K Sell
21,817
-48,784
-69% -$99.3K ﹤0.01% 6855
2021
Q3
$177K Buy
+70,601
New +$196K ﹤0.01% 5311
2021
Q2
Sell
-6,037
Closed -$21K 8910
2021
Q1
$21K Sell
6,037
-37,851
-86% -$211K ﹤0.01% 6755
2020
Q4
$208K Buy
43,888
+23,020
+110% +$119K ﹤0.01% 4031
2020
Q3
$101K Sell
20,868
-12,218
-37% -$57.9K ﹤0.01% 4192
2020
Q2
$108K Buy
+33,086
New +$314K ﹤0.01% 3853

Other funds holding CEMI

Group One Trading's CEMI Position: Q1 2023 in Review

Group One Trading sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 29,315 shares — an estimated $11.5K sold.

Group One Trading first reported a position in CEMI in Q2 2020 and held it in 10 quarters. The position peaked at $208K in Q4 2020. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

  • Group One Trading reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 29,315 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $11.5K.
  • Group One Trading first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Chembio diagnostics, Inc. position peaked at $208K in Q4 2020.
  • 30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.